Work

Coronavirus Disease 2019 Convalescent Plasma Utilization in the United States: Data From the National Inpatient Sample

Year: 2023

Type: article

Study design: Observational Study

Abstract: Coronavirus disease 2019 (COVID-19) convalescent plasma (CCP) use between October and December 2020 was characterized using the National Inpatient Sample database. CCP was administered in 18.0% of COVID-19-associated hospitalizations and was strongly associated with older age and increased disease severity. There were disparities in the receipt of CCP by race and ethnicity, geography, and insurance.

Source: Clinical Infectious Diseases

DOI: 10.1093/cid/ciad185

Authors: Evan M Bloch, Ruchika Goel, Xianming Zhu, Eshan U Patel, Shmuel Shoham, David J Sullivan, Kelly A Gebo, Arturo Casadevall, Aaron A R Tobian

Institutions: Johns Hopkins University, SIU Medicine, Johns Hopkins Medicine

Language: English

Topic: COVID-19 Clinical Research Studies

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: bronze

Funders: Center for AIDS Research, University of Washington, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G1592026562, G2591216802, G761535178, Johns Hopkins HIV Epidemiology and Prevention Sciences Training Program

OpenAlex ID: W4361301476

FWCI: 0.373

Cites: 12

Cited by: 2

Related to: 10